Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company

November 4, 2021 1:45 PM
Needham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles